Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ClotPro-Guided Thrombolysis for Pulmonary Embolism
NCT06667882Completed
- Sponsor
- Semmelweis University
- Start
- Dec 2021
- Primary completion
- Oct 2024
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of tissue-plasminogen activator in pulmonary embolism (PE) (2 arms), sponsored by Semmelweis University. Primary endpoints: Major, life threatening bleeding due to profuse bleeding, Major, life threatening bleeding due to intracranial haemorrhage and 1 more. Started Dec 2021; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT06667882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06667882.